Measure ID
Measure Name
“Public Note”
Error Notice
H3-287
Documentation of Current Medications in the Medical Record
The denominators reported for H3-287 and H3-288 should be the same since the measures share the same denominator definition.
There are slight differences in denominator inclusion encounter codes between H3-287 and H3-288, so the denominators reported for H3-287 and H3-288 should not be assumed to be the same.
H3-288
Pain Assessment and Follow-up
H3-401
Opioid Therapy Follow-up Evaluation
The denominators reported for H3-401 and H3-403 should be the same since the measures share the same denominator definition.
Since H3-401 specifications include:
“NOTE: Include only patients that have 6 weeks opioid use through September 30 of the performance period. This will allow the follow-up evaluation of at least 90 days after opioid therapy within the reporting year,“
there is a difference in denominator measurement periods between H3-401 and H3-403, so the denominators reported for H3-401 and H3-403 should not be assumed to be the same.
H3-403
Evaluation or Interview for Risk of Opioid Misuse
H1-255
Follow-up Care for Children Prescribed ADHD Medication (ADD)
This measure is reported as two rates. The denominators for Rate 1 and Rate 2 should be the same.
There are differences in denominator specification between Rate 1 and Rate 2 for H1-255, so the denominators for Rate 1 and Rate 2 should not be assumed to be the same.
M1-255
There are differences in denominator specification between Rate 1 and Rate 2 for M1-255, so the denominators for Rate 1 and Rate 2 should not be assumed to be the same.
D5-T07
Innovative Measure: Diabetes Outpatient Care Management (Care Coordination)
There are differences in denominator specification between Rate 1 and Rate 2 for D5-T07, so the denominators for Rate 1 and Rate 2 should not be assumed to be the same.